VP, Business Development Transactions
Description
Who We Are
BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.
Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities.
Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options.
- Lead the financial assessment and valuation of potential mergers, acquisitions, licensing deals, and business opportunities focused on technologies or medicines that address genetically defined conditions.
- Develop financial models to forecast returns, assess risks, and support data-driven decision making in high-stakes transactions.
- Lead transaction design, negotiations, and deal signing, including deal terms, payment structures, and financial contingencies, ensuring alignment with the company's strategic and financial goals.
- Collaborate with legal and finance teams to manage due diligence processes and ensure contractual compliance.
- Work closely with the CFO and finance team to ensure alignment of business development activities with the company's overall financial strategy.
- Communicate transaction progress, risks, and impacts to executive leadership and other stakeholders.
- Stay updated on industry trends, valuation benchmarks, and the competitive landscape to inform transaction strategies and decisions.
- Provide insights into financial impacts of market changes and ensure the company's transactions remain aligned with industry best practices.
- High impact valuations: Deliver accurate, insightful valuations that guide 100% of business development transactions, leading to data-driven decisions.
- Transaction Success Rate: Lead or advise on transactions that meet or exceed financial performance expectations with an aim of multiple deals per year.
- Optimized Financial Structures: Design financial structures that optimize cash flow, mitigate risk, and ensure long term financial sustainability for each transaction.
- Industry Benchmarking: Implement continuous competitive analysis to maintain top tier valuation practices and benchmarking aligned with the evolving biotech market.
- At least 15 years in Finance, Corporate Development or M&A within biotech or pharmaceuticals.
- Proven Track Record of valuation, financial modeling and executing complex transactions in life sciences sector; including mergers, acquisitions and strategic alliances.
- Advance degree in Finance, Business, Life Sciences or a related field (MBA, CFA or CPA preferred)
- Excellent analytical, negotiation, and cross-functional collaboration skills, with the ability to work effectively with both finance and business development teams.
An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.